Programmed Cell Death Ligand 1 Protects Against Death in Neonatal Sepsis

被引：0
|
作者：
Wakeley, Michelle E.
De Paepe, Monique E.
Chung, Chun-Shiang
Ayala, Alfred
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Woman & Infants Hosp, Providence, RI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2019年 / 229卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [41] Programmed Cell Death Ligand 1 Expression in Canine Cancer
    Shosu, Kazuha
    Sakurai, Masashi
    Inoue, Kumi
    Nakagawa, Takayuki
    Sakai, Hiroki
    Morimoto, Masahiro
    Okuda, Masaru
    Noguchi, Shunsuke
    Mizuno, Takuya
    IN VIVO, 2016, 30 (03): : 195 - 204
  • [42] Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [43] Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type
    Jo, Jae-Cheol
    Kim, Misung
    Choi, Yunsuk
    Kim, Hyun-Jung
    Kim, Ji Eun
    Chae, Seoung Wan
    Kim, Hawk
    Cha, Hee Jeong
    ANNALS OF HEMATOLOGY, 2017, 96 (01) : 25 - 31
  • [44] Expression of Programmed Cell Death 1 and Programmed Cell Death Ligand 1 in Extranodal NK/T-Cell Lymphoma, Nasal Type
    Jo, Jae-Cheol
    Choi, Yunsuk
    Cha, Hee Jeong
    Lee, Eun Hee
    Kang, Eun Kyoung
    Kim, Hawk
    BLOOD, 2015, 126 (23)
  • [45] Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold
    Qin, Mingze
    Cao, Qi
    Wu, Xia
    Liu, Chunyang
    Zheng, Shuaishuai
    Xie, Hongbo
    Tian, Ye
    Xie, Jun
    Zhao, Yanfang
    Hou, Yunlei
    Zhang, Xian
    Xu, Boxuan
    Zhang, Haotian
    Wang, Xiaobo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [46] Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
    Xiaoyun Li
    Qin Zeng
    Fengjiao Xu
    Yuying Jiang
    Zhongmei Jiang
    Molecular Diversity, 2023, 27 : 1935 - 1955
  • [47] SAR study of small molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
    Kawashita, Seiji
    Aoyagi, Koichi
    Fukushima, Kyoko
    Hantani, Rie
    Naruoka, Shiori
    Tanimoto, Atsuo
    Hori, Yuji
    Toyonaga, Yukiyo
    Yamanaka, Hiroshi
    Miyazaki, Susumu
    Hantani, Yoshiji
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (05) : 914 - 929
  • [48] Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
    Niedzwiedzka-Rystwej, Paulina
    Majchrzak, Adam
    Aksak-Was, Bogusz
    Serwin, Karol
    Czajkowski, Zenon
    Grywalska, Ewelina
    Korona-Glowniak, Izabela
    Rolinski, Jacek
    Parczewski, Milosz
    CELLS, 2022, 11 (12)
  • [49] Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type
    Jae-Cheol Jo
    Misung Kim
    Yunsuk Choi
    Hyun-Jung Kim
    Ji Eun Kim
    Seoung Wan Chae
    Hawk Kim
    Hee Jeong Cha
    Annals of Hematology, 2017, 96 : 25 - 31
  • [50] A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1
    Gaule, Patricia
    Smithy, James W.
    Toki, Maria
    Rehman, Jamaal
    Patell-Socha, Farah
    Cougot, Delphine
    Collin, Philippe
    Morrill, Paul
    Neumeister, Veronique
    Rimm, David L.
    JAMA ONCOLOGY, 2017, 3 (02) : 256 - 259
12345